Search

Search Constraints

You searched for: Author/Creator Wang, K

Search Results

5. 357 GLS-010 (Zimberelimab), a novel fully human anti-PD-1 mAb in chinese patients with recurrent/metastatic cervical cancer: results from a multicenter, open-label, single-arm phase II trial. (13th November 2020)